Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 10803
TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570361(US11434232, Compound WX17)
Affinity DataIC50: 12nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570381(US11434232, Compound WX36)
Affinity DataIC50: 14nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570385(US11434232, Compound WX40)
Affinity DataIC50: 15nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570382(US11434232, Compound WX37)
Affinity DataIC50: 16nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570369(US11434232, Compound WX24)
Affinity DataIC50: 18nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570380(US11434232, Compound WX35)
Affinity DataIC50: 19nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570400(US11434232, Compound WX57 | US11434232, Compound W...)
Affinity DataIC50: 20nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570397(US11434232, Compound WX52)
Affinity DataIC50: 20nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570357(US11434232, Compound WX13)
Affinity DataIC50: 24nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570394(US11434232, Compound WX49)
Affinity DataIC50: 26nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570399(US11434232, Compound WX54)
Affinity DataIC50: 27nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570366(US11434232, Compound WX21)
Affinity DataIC50: 27nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570400(US11434232, Compound WX57 | US11434232, Compound W...)
Affinity DataIC50: 28nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570387(US11434232, Compound WX42)
Affinity DataIC50: 29nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570391(US11434232, Compound WX46)
Affinity DataIC50: 31nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570396(US11434232, Compound WX51)
Affinity DataIC50: 32nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570377(US11434232, Compound WX32)
Affinity DataIC50: 35nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570375(US11434232, Compound WX30)
Affinity DataIC50: 35nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570376(US11434232, Compound WX31)
Affinity DataIC50: 39nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570356(US11434232, Compound WX12)
Affinity DataIC50: 41nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570395(US11434232, Compound WX50)
Affinity DataIC50: 42nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570384(US11434232, Compound WX39)
Affinity DataIC50: 42nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570401(US11434232, Compound WX56)
Affinity DataIC50: 46nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570373(US11434232, Compound WX28)
Affinity DataIC50: 47nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570358(US11434232, Compound WX14)
Affinity DataIC50: 50nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570349(US11434232, Compound WX05)
Affinity DataIC50: 53nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570392(US11434232, Compound WX47)
Affinity DataIC50: 64nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570389(US11434232, Compound WX44)
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570367(US11434232, Compound WX22)
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570388(US11434232, Compound WX43)
Affinity DataIC50: 65nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570365(US11434232, Compound WX20)
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570390(US11434232, Compound WX45)
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570379(US11434232, Compound WX34)
Affinity DataIC50: 69nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570346(US11434232, Compound WX02)
Affinity DataIC50: 72nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570347(US11434232, Compound WX03)
Affinity DataIC50: 72nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570351(US11434232, Compound WX07)
Affinity DataIC50: 75nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570383(US11434232, Compound WX38)
Affinity DataIC50: 78nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570386(US11434232, Compound WX41)
Affinity DataIC50: 78nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570354(US11434232, Compound WX10)
Affinity DataIC50: 80nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570364(US11434232, Compound WX19)
Affinity DataIC50: 81nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570362(US11434232, Compound WX18)
Affinity DataIC50: 83nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570398(US11434232, Compound WX53)
Affinity DataIC50: 83nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570348(US11434232, Compound WX04)
Affinity DataIC50: 91nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570370(US11434232, Compound WX25)
Affinity DataIC50: 92nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570374(US11434232, Compound WX29)
Affinity DataIC50: 96nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570360(US11434232, Compound WX16)
Affinity DataIC50: 97nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570393(US11434232, Compound WX48)
Affinity DataIC50: 105nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570368(US11434232, Compound WX23)
Affinity DataIC50: 115nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570345(US11434232, Compound WX01)
Affinity DataIC50: 119nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Wuxi Biocity Biopharmaceutics

US Patent
LigandPNGBDBM570371(US11434232, Compound WX26)
Affinity DataIC50: 123nMAssay Description:TR/ATRIP(h) was incubated in assay buffer containing 50 nM GST-cMyc-p53 and Mg/ATP (according to concentration required). The reaction was initiated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: